TITLE:
A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

CONDITION:
Secondary Hyperparathyroidism

INTERVENTION:
Placebo

SUMMARY:

      This 6 month study will assess an investigational medication for patients on dialysis with
      secondary hyperparathyroidism. The study will look at the effects on parathyroid hormone,
      calcium and phosphorus levels.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Patients must be receiving hemodialysis; have elevated parathyroid hormone levels; not be
        pregnant or nursing; and not have had a heart attack in the last 3 months.
      
